Other aplastic anemias and other bone marrow failure syndromes
Notes: Blackfan-Diamond syndrome ; Congenital (pure) red cell aplasia ; Familial hypoplastic anemia ; Primary (pure) red cell aplasia ; Red cell (pure) aplasia of infants ; Fanconi’s anemia ; Pancytopenia with malformations ; Leukoerythroblastic anemia ; Myelophthisic anemia ; Panmyelophthisis ; Hypoplastic anemia NOS ; Medullary hypoplasia ; code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) ; acquired red cell aplasia (D60.9) ; pancytopenia (due to) (with) aplastic anemia (D61.9) ; pancytopenia (due to) (with) bone marrow infiltration (D61.82) ; pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01) ; pancytopenia (due to) (with) hairy cell leukemia (C91.4-) ; pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-) ; pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82) ; pancytopenia (due to) (with) myeloproliferative disease (D47.1) ; idiopathic myelofibrosis (D47.1) ; myelofibrosis NOS (D75.81) ; myelofibrosis with myeloid metaplasia (D47.4) ; primary myelofibrosis (D47.1) ; secondary myelofibrosis (D75.81) ; neutropenia (D70.-) ; pancytopenia (due to) (with) myelodysplastic syndromes (D46.-) ; aplastic anemia due to antineoplastic chemotherapy (D61.1) ; aplastic anemia due to drugs (D61.1) ; , if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)